Newsfeeds - Spark Newswire

1 minute read

Redhill Biopharma US Patent & Trademark Office Abstract For Co.’s ‘SPHINGOSINE KINASE 2 INHIBITOR FOR TREATING CORONAVIRUS INFECTION’

Today, 9:47 PM

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=7433&p=149&f=G&l=50&d=PG01&S1=20211021.PD.&OS=PD/20211021&RS=PD/20211021

RDHL

1 minute read

Events
News

RedHill Biopharma To Present At The BIO-Europe 2021 Conference

By Benzinga Newsdesk

Today, 9:47 PM

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that Mr. Adi Frish, RedHill's Chief Corporate & Business

RDHL

4 minute read

52 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:47 PM

Gainers

AEHR

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 9:47 PM

ADMP

1 minute read

RedHill Biopharma Highlights Recent ADS Purchases By Management

By Bill Haddad

Today, 9:47 PM

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that members of its board of directors and senior management, including the

RDHL

5 minute read

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal

By Shanthi Rexaline

Today, 9:47 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)

ABEO

1 minute read

News

RedHill Biopharma Ltd Announces Talicia(R) Added To Medi-Cal CDL

By Benzinga Newsdesk

Today, 9:47 PM

RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements Addition of Talicia® by Medi-Cal Fee-For-Service (FFS) Contract Drug List (CDL) with no

RDHL

2 minute read

16 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 9:47 PM

Gainers Marine Petroleum Trust (NASDAQ: MARPS) rose 25.4% to $6.29 in pre-market trading after gaining 8% on Monday.

AGFY

4 minute read

44 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:47 PM

Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.

ADVM

1 minute read

Why Did RedHill Biopharma Shares Jump 12% Monday?

By Vandana Singh

Today, 9:47 PM

RedHill Biopharma Ltd (NASDAQ:RDHL) has reported new data from the opaganib global Phase 2/3 study in hospitalized COVID-19 patients with severe…

RDHL